Advances in Highly Active Antiretroviral
The management of HIV/AIDS normally includes the use of multiple antiretroviral drugs in an attempt to control HIV infection. There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle. The use of multiple drugs that act on different viral targets is known as highly active antiretroviral therapy (HAART). HAART decreases the patient's total burden of HIV, maintains function of the immune system, and prevents opportunistic infections that often lead to death. HAART also prevents the transmission of HIV between serodiscordant same sex and opposite sex partners so long as the HIV-positive partner maintains an undetectable viral load.
Sample Chapter(s)
Preface (95 KB)
Components of the Book:
  • Chapter1
    Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study
  • Chapter2
    Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort study
  • Chapter3
    The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV-TB co-infected Indian patients receiving rifampicin based antituberculosis treatment
  • Chapter4
    Fertility desire and associated factors among clients on highly active antiretroviral treatment at finoteselam hospital Northwest Ethiopia: a cross sectional study
  • Chapter5
    Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report
  • Chapter6
    Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study
  • Chapter7
    Rate of candidiasis among HIV-infected children in Spain in the era of highly active antiretroviral therapy (1997–2008)
  • Chapter8
    Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study
  • Chapter
    Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
  • Chapter10
    Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
  • Chapter11
    New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy)
  • Chapter12
    Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review
  • Chapter13
    Disseminated Rhodococcus equi infection in HIV infection despite highly active antiretroviral therapy
  • Chapter14
    Immune restoration disease and changes in CD4+ T-cell count in HIV- infected patients during highly active antiretroviral therapy at Zewditu memorial hospital, Addis Ababa, Ethiopia
  • Chapter15
    Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa
Readership: Students, academics, teachers and other people attending or interested in medicine or health care.
Chenglong Liu, Department of Medicine, Georgetown University, Washington, USA

Marshall J Glesby,, Division of Infectious Diseases, Weill Cornell Medical College, New York, USA

Howard Minkoff, Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, USA

Elijah Oyoo-Okoth, School Natural Resources and Environmental Studies, Karatina University, Karatina, Kenya

Monique van Lettow, Dalla Lana School of Public Health University of Toronto, Toronto, Canada

.Megan Landes, Department of Medicine at St Michaels Hospital, University of Toronto, Toronto, Canada

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top